10-Q: Arogo Capital Acquisition Corp. Reports Q2 2024 Results, Faces Nasdaq Delisting Risk

Arogo Capital Acquisition Corp. reported a net loss for the second quarter of 2024 and is facing potential delisting from Nasdaq due to non-compliance with listing requirements.

Summary

• Arogo Capital Acquisition Corp. reported a net loss of $448,321 for the three months ended June 30, 2024, and a net loss of $637,044 for the six months ended June 30, 2024.
• The company's operating costs were $638,219 for the quarter and $997,211 for the six-month period, with franchise taxes adding $21,600 and $57,200 respectively.
• Unrealized gains on marketable securities held in the trust account partially offset these losses, amounting to $256,129 for the quarter and $507,258 for the six months.
• As of June 30, 2024, Arogo had $78,427 in cash and a working capital deficit of $4,763,546.
• The company has until December 29, 2024, to complete a business combination, and faces potential liquidation if it fails to do so.
• Arogo is facing potential delisting from Nasdaq due to not meeting the minimum Market Value of Listed Securities and total holder requirements.
• The company has requested a hearing with Nasdaq to appeal the delisting notice.
• The company has extended the period to complete a business combination to December 29, 2024, through sponsor contributions to the trust account.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to the company's financial losses, potential delisting from Nasdaq, and the need for additional financing. The termination of a previous merger agreement and the abandonment of a registration statement further contribute to the negative sentiment.

Positives

• The company has extended the period to complete a business combination to December 29, 2024.
• The company has $19,647,685 in cash held in trust as of June 30, 2024.
• The company is actively seeking a business combination and has entered into a new agreement with Ayurcann Holdings Corp.

Negatives

• Arogo reported a net loss of $448,321 for the three months ended June 30, 2024.
• The company has a working capital deficit of $4,763,546 as of June 30, 2024.
• Arogo is facing potential delisting from Nasdaq due to non-compliance with listing rules.
• The company terminated a previous merger agreement with Eon Reality, Inc.
• The company's registration statement on Form S-4 was declared abandoned by the SEC.

Risks

• The company may not be able to complete a business combination by December 29, 2024, leading to liquidation.
• There is a risk of delisting from Nasdaq if the company cannot regain compliance with listing requirements.
• The company's financial statements include a going concern warning due to the uncertainty of completing a business combination.
• The company may need to raise additional funds to meet working capital needs.
• Unstable market and economic conditions could adversely affect the company's ability to complete a business combination.
• A new 1% U.S. federal excise tax could be imposed on the company in connection with future redemptions of public shares.

Future Outlook

The company is focused on completing a business combination by December 29, 2024, and is working to regain compliance with Nasdaq listing requirements. The company's future is dependent on its ability to complete a business combination and secure additional financing.

Management Comments

• Management has determined that the Company will need to raise additional funds to meet the working capital needs of the Company prior to the consummation of an initial business combination or the winding up of the Company.
• Management has determined that if the Company is unsuccessful in consummating an initial business combination within the prescribed period of time from the closing of the Initial Public Offering, the requirement that the Company cease all operations, redeem the Public Shares and thereafter liquidate and dissolve raises substantial doubt about the ability to continue as a going concern.

Industry Context

The report reflects the challenges faced by many SPACs in the current market, including difficulties in finding suitable merger targets and maintaining listing compliance. The termination of the Eon Reality merger and the subsequent agreement with Ayurcann Holdings Corp. highlight the dynamic nature of the SPAC market.

Comparison to Industry Standards

• The financial performance of Arogo is below average compared to other SPACs, particularly in terms of profitability and operating costs.
• The company's cash position is relatively low compared to other SPACs of similar size, which may limit its ability to pursue larger acquisition targets.
• The delisting notice from Nasdaq is a significant concern, as many SPACs struggle to maintain listing compliance due to market volatility and lack of investor interest.
• The company's reliance on sponsor funding for extensions is common among SPACs, but it also indicates a lack of independent financial strength.
• The termination of the Eon Reality merger is not uncommon in the SPAC market, where many deals fall through due to various reasons, including due diligence issues and market conditions.

Related Party Transactions

• The company pays the Sponsor $10,000 per month for office space, utilities, and administrative support.
• The Sponsor has provided working capital loans to the company.
• The Sponsor has made monthly deposits into the trust account to extend the business combination period.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company fails to complete a business combination and is liquidated.
• Shareholders may experience further dilution if the company raises additional capital.
• Employees of the company may face uncertainty regarding their future employment.
• The company's suppliers and service providers may be impacted by the company's financial difficulties.

Next Steps

• The company will seek to complete a business combination by December 29, 2024.
• The company will attend a hearing with Nasdaq to appeal the delisting notice.
• The company will continue to seek additional financing to meet working capital needs.
• The company will work to finalize the business combination with Ayurcann Holdings Corp.

Key Dates

Keywords

SPAC, business combination, Nasdaq delisting, financial results, merger, trust account, working capital, redemption, excise tax, Ayurcann Holdings Corp